These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18558197)

  • 1. Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.
    Durkin ET; Jones KA; Elnaggar D; Shaaban AF
    J Pediatr Surg; 2008 Jun; 43(6):1142-7. PubMed ID: 18558197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells.
    Carrier E; Lee TH; Busch MP; Cowan MJ
    Blood; 1995 Dec; 86(12):4681-90. PubMed ID: 8541562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
    Gaines BA; Colson YL; Kaufman CL; Ildstad S
    Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens.
    Blazar BR; Taylor PA; Bluestone JA; Vallera DA
    Blood; 1996 May; 87(10):4463-72. PubMed ID: 8639809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice.
    Wang By; El-Badri NS; Cherry ; Good RA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14632-6. PubMed ID: 9405664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
    Hayashi S; Peranteau WH; Shaaban AF; Flake AW
    Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
    Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
    Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine liver allograft transplantation: tolerance and donor cell chimerism.
    Qian S; Demetris AJ; Murase N; Rao AS; Fung JJ; Starzl TE
    Hepatology; 1994 Apr; 19(4):916-24. PubMed ID: 8138266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment.
    Shaaban AF; Kim HB; Gaur L; Liechty KW; Flake AW
    Exp Hematol; 2006 Sep; 34(9):1278-87. PubMed ID: 16939821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and long-lasting peripheral chimerism after allogeneic intestinal transplantation in MGH miniature swine.
    Ishikawa Y; Hirakata A; Griesemer AD; Etter J; Moran S; Weiner J; Shimizu A; Yamada K
    Transplantation; 2010 Feb; 89(4):417-26. PubMed ID: 20177343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
    Koch U; Korngold R
    Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine.
    Mathes DW; Solari MG; Gazelle GS; Butler PE; Wu A; Nazzal A; Nielsen GP; Huang CA; Sachs DH; Lee WP; Randolph MA
    Transpl Int; 2014 Oct; 27(10):1086-96. PubMed ID: 24963743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.
    Hanash AM; Levy RB
    Blood; 2005 Feb; 105(4):1828-36. PubMed ID: 15494429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts.
    Li X; Faustman D
    Transplantation; 1993 Apr; 55(4):940-6. PubMed ID: 8475570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.